| SACHEM, Inc. and Dr. Steven M. Cramer Sign Agreement to Commercialize Displacement Technology |
|
Austin, TX - January 7, 2002 - SACHEM, Inc. announced today a strategic agreement with Dr. Steven M. Cramer to develop and commercialize displacement chromatography technology. Displacement chromatography is a powerful technique for the purification of proteins and other biomolecules. Overall, this agreement reinforces the strong momentum in new technology improvements for downstream processing.“Displacement chromatography is an exciting approach to protein purification. We are very pleased to have reached this agreement with Dr. Cramer and are eager to match the strengths of SACHEM with this intellectual property”, said Richard Goodin, VP of R&D for SACHEM Inc. “This agreement with Dr. Cramer is a major step forward in our drive to bring this technology to the user.” SACHEM intends to use its high purity manufacturing capability to provide the products, which make this technology effective. They will provide a complete package including technical expertise and reagents to allow full economic benefits to the user. Dr. Steven M. Cramer is a Professor of Chemical Engineering at Rensselaer Polytechnic Institute. He has become a recognized expert in the fields of Chromatographic Bioprocessing and Separation Science and is the Editor of the journal “Separation Science and Technology”. Dr. Cramer received his PhD and MS in Chemical Engineering from Yale University and a BS in Biomedical Engineering from Brown University. SACHEM, Inc. is a leading worldwide supplier of high–purity products and services to the electronics, catalyst, and biopharmaceutical markets. Based in Austin, TX, SACHEM has facilities in Asia, Europe and the United Sates. In addition, SACHEM’s Cleburne, Texas facility is registered with the US Food and Drug Administration for the manufacture of products under cGMP. This initiative in displacement chromatography further strengthens SACHEM’s commitment to the biotechnology and pharmaceutical sector. SACHEM, Inc., is based in Austin, Texas, and serves the high-purity requirements of its customers worldwide in the semiconductor, polymer, pharmaceutical, catalyst, and agricultural chemical markets. |